Top

Published in:

01-06-2023 | Flucloxacillin | News item

PI updates for ceftriaxone, flucloxacillin, teicoplanin, tofacitinib

Published in: Reactions Weekly | Issue 1/2023

Excerpt

The Ireland Health Products Regulatory Authority (HPRA) has published product information (PI) updates for ceftriaxone, flucloxacillin, teicoplanin and tofacitinib which were recommended by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee. …

Product information updates recommended by Pharmacovigilance Risk Assessment Committee HPRA Drug Safety Newsletter : No. 112, et al. Jun 2023. Available from: URL: https://www.hpra.ie/docs/default-source/publications-forms/newsletters/hpra-drug-safety-newsletter-edition-112.pdf?sfvrsn=5

Title: PI updates for ceftriaxone, flucloxacillin, teicoplanin, tofacitinib
Publication date: 01-06-2023
Publisher: Springer International Publishing
Keywords: Flucloxacillin
Ceftriaxone
Teicoplanin
Encephalopathy
Hypoglycemia
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41677-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

PI updates for ceftriaxone, flucloxacillin, teicoplanin, tofacitinib

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Magnesium-sulfate/potassium-sulfate/simethicone/sodium-sulfate

Rituximab

Multiple drugs

Pembrolizumab

Antidepressants

Betamethasone-sodium-phosphate